Literature DB >> 2203592

Anti-centromere antibodies (ACA).

C G Kallenberg1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2203592     DOI： 10.1007/bf02205562

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  26 in total

1.  Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma.

Authors:  W C Earnshaw; N Rothfield
Journal:  Chromosoma       Date:  1985       Impact factor: 4.316

2.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  Significance of anticentromere antibody in idiopathic Raynaud's syndrome.

Authors:  J Sarkozi; A A Bookman; P Lee; E C Keystone; M J Fritzler
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

4.  Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Authors:  C G Kallenberg; A A Wouda; M H Hoet; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

5.  Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells.

Authors:  H H Guldner; H J Lakomek; F A Bautz
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

6.  Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies.

Authors:  C G Kallenberg; J van der Meulen; G W Pastoor; J A Snijder; T E Feltkamp; T H The
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

7.  Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.

Authors:  N Nagata; U Hurtenbach; E Gleichmann
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  The CREST syndrome: a distinct serologic entity with anticentromere antibodies.

Authors:  M J Fritzler; T D Kinsella
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases.

Authors:  F C Powell; A L Schroeter; E R Dickson
Journal:  Q J Med       Date:  1987-01
View more
  2 in total

1.  Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction.

Authors:  Julien Guiot; Makon-Sébastien Njock; Béatrice André; Fanny Gester; Monique Henket; Dominique de Seny; Catherine Moermans; Michel G Malaise; Renaud Louis
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

2.  Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.

Authors:  Nobuo Kuramoto; Koichiro Ohmura; Katsunori Ikari; Koichiro Yano; Moritoshi Furu; Noriyuki Yamakawa; Motomu Hashimoto; Hiromu Ito; Takao Fujii; Kosaku Murakami; Ran Nakashima; Yoshitaka Imura; Naoichiro Yukawa; Hajime Yoshifuji; Atsuo Taniguchi; Shigeki Momohara; Hisashi Yamanaka; Fumihiko Matsuda; Tsuneyo Mimori; Chikashi Terao
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.